about
Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents.A Phase 1/2 Study of evofosfamide, A Hypoxia-Activated Prodrug with or without Bortezomib in Subjects with Relapsed/Refractory Multiple MyelomaPhase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma
P50
description
researcher
@en
wetenschapper
@nl
name
Kalvis Hornburg
@en
Kalvis Hornburg
@nl
type
label
Kalvis Hornburg
@en
Kalvis Hornburg
@nl
prefLabel
Kalvis Hornburg
@en
Kalvis Hornburg
@nl
P31
P496
0000-0002-3361-6560